The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe, held in London from April 8th to 10th, aims to address common concerns among European Biomarker, Translational, and Clinical Development professionals, such as:
How can we ensure the clinical validation, adoption, and scalability of novel testing technologies beyond genomics in Europe?
Biopharma companies are collaborating with regulators and IVD providers to validate and commercialize novel technologies, including digital pathology, omics, liquid biopsies, cell sequencing, and multiplexing.
How can we streamline biomarker validation and IVDR-compliant companion diagnostics co-development beyond oncology?
Explore the newest breakthroughs in blood-based biomarkers, CE-marked genetic panels, and imaging to improve patient selection and monitoring in precision medicine for autoimmune, metabolic, neurological, and uncommon disorders.
How can we work with national and multi-institutes within Europe to accelerate the clinical adoption of biomarkers?
Discover how major healthcare institutes, infrastructure, and consortiums across Europe develop and execute multi-center efforts to increase the adoption, validation, and market access of novel biomarkers and IVDR-compliant diagnostics.
Learn more about biomarker research, clinical validation, CDx development, and commercialization to improve your skills both upstream and downstream.
About Hanson Wade Group - 15th World Clinical Biomarkers & CDx Europe
Welcome to the 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe.
With drug-diagnostic co-development partnerships fueling advances in diagnostic testing for Alzheimer’s, Multiple Sclerosis, cardiovascular disease, rare genetic disorders, and cancer, 2025 is poised as a critical year for Europe’s precision medicine community. However, developing, clinically validating, regulatory filing, and commercializing biomarkers and in vitro diagnostics remains no easy feat, as knowledge gaps persist in validating surrogate endpoints, co-developing scalable diagnostic testing workflows and infrastructure, navigating reimbursement pathways, and harmonizing drug-diagnostic IVDR-adherence for approval in unmet patient need.
The 15th World Clinical Biomarkers & Companion Diagnostics Summit Europe returns as the industry-leading end-to-end forum for Europe’s precision medicine community. Serving as your premium connection-making platform, this summit will unite over 170 key European stakeholders to accelerate precision drugs from discovery through to commercialization for patients in need.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.